Prelude Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Prelude Capital Management’s Portfolio EWTX Stock Details EWTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$1.03M	Sell
2025 Q3	$798K	Buy
2025 Q2	$509K	Sell
2025 Q1	$1.1M	Buy
2024 Q4	$885K	Buy
2024 Q3	$782K	Buy